Pure Red Cell Aplasia Associated With Recipient B‐Cell Mixed Chimerism Successfully Treated With Rituximab

Documenti analoghi

• Pure Red Cell Aplasia and C3‐Dominant Glomerulonephritis Secondary to Parvovirus B19 in Post Kidney Transplantation Patient: A Case Report
  di: Sirihatai Konwai, et al.
  Pubblicazione: (2025)
• Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
  di: Gintarė Mierkienė, et al.
  Pubblicazione: (2025)
• Preemptive Rituximab for Epstein–Barr Virus Reactivation After Hematopoietic Cell Transplantation: Necessary for All?
  di: Anna Beatriz Coelho de Souza, et al.
  Pubblicazione: (2025)
• Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
  di: Madeleine R. Heldman, et al.
  Pubblicazione: (2024)
• Cytomegalovirus Infection After Chimeric Antigen Receptor T‐Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies
  di: Juhui Han, et al.
  Pubblicazione: (2025)